Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MERVIN G WOLFF

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1154411213
CMS profile
188922
Location
DETROIT, MI

General Payments · PY2018–2024

$110,295.03

  • Reported across 61 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$61,020.92

26 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $60,853.42 25
Food and Beverage $167.50 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $60,853.42 25
Inari Medical, Inc. $167.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $340.19 5
PY2019 $91.75 1
PY2021 $128.75 1
PY2022 $20,775.24 13
PY2023 $27,938.18 15
PY2024 $61,020.92 26

Payment records · PY2024 (26)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Inari Medical, Inc. $167.50 02/28/2024 Food and Beverage Undisputed 01/23/2026 1140175048 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137699002 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137699004 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137699006 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137699008 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137699010 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137699012 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137699014 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137699016 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137699018 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137699020 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137699022 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137699024 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137699026 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137699028 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137699030 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137699032 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137699034 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137699036 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137699038 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137699040 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137699042 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137699044 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,263.34 12/04/2024 Consulting Fee Undisputed 01/23/2026 1137699046 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,426.67 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137699048 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,576.67 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137699050 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.